Business Today
Loading...

COVID-19 vaccine: Govt issues company-wise supply plan of Remdesivir to states, UTs

The companies have been instructed to ensure timely supplies of Remdesivir to all states/UTs strictly as per the supply plan

twitter-logoBusinessToday.In | May 8, 2021 | Updated 15:08 IST
COVID-19 vaccine: Govt issues company-wise supply plan of Remdesivir to states, UTs
The development comes in continuation to the allocation of Remdesivir to states/UTs done on Friday, May 7

The Centre on Saturday, May 8, issued a company-wise supply plan of antiviral drug Remdesivir to states and Union Territories (UTs). Remdesivir is a key drug used in the treatment of COVID-19 patients.

"The company-wise supply plan of Remdesivir for the period April 21 to May 16 has been issued to states/UTs," read an official statement by the Ministry of Chemicals and Fertilizers.

The plan has been readied in consultation with the marketing companies, the statement noted adding that the companies have been instructed to ensure timely supplies to all states/UTs strictly as per the supply plan.

The development comes in continuation to the allocation of Remdesivir to states/UTs done on Friday, May 7.

Also Read: Remdesivir for COVID-19 patients: No evidence of anti-viral drug's effectiveness, says WHO

To ensure smooth supply of Remdesivir used in the treatment of COVID-19 across the country, the allocation of the antiviral drug to the states and union territories has been made up to May 16, Union Chemicals and Fertilisers Minister Sadananda Gowda said on Friday.

The production capacity of Remdesivir has been increased to 1.03 crore vials per month, up from 38 lakh vials per month earlier, the minister had said on Tuesday.

"Considering the requirement of Remdesivir in every state and ensuring it's adequate availability, allocation of #Remdesivir has been made up to 16th May 2021. dis will ensure smooth supply of Remdesivir across country so that no patient face difficulty in dis #pandemic time," Gowda said in a tweet.

The minister also enclosed a letter by Department of Pharma Joint Secretary Navdeep Rinwa and Ministry of Health & Family Welfare Director Rajiv Wadhawan, giving details of the updated allocation plan valid for the period April 21 to May 16 being made for states/UTs.

The allotment is being made for the states/UTs and it is the state governments and UTs that has to monitor proper distribution, covering government and private hospitals as appropriate and in line with judicious use, the letter said.

"State governments/UTs are advised to place adequate purchase orders with the marketing companies immediately, if they have not already done so, for the quantity that they want to purchase out of the allocation for the state/UT as per supply plan in close coordination with the liaison officers of the companies," it added.

Also Read: Remdesivir only for hospitalised patients low on oxygen, says Health Ministry

The coordination with private distribution channels in the state could also be made, the letter said.

"The nodal officers of the state governments has to coordinate and follow up with the marketing companies to get delivery of Remdesivir injection in time as per the daily requirements", the letter written to additional chief secretary/ principal secretary and secretary health of all states/UTs said.

Demand for Remdesivir has gone up manifold in the country amid a massive spike in COVID infections.

The government has already waived customs duty on Remdesivir, it's raw materials and other components used to make the antiviral drug in order to halp augment domestic availability and reduce the cost of the injection.

On April 11, in view of increased demand for Remdesivir, the Centre banned the export of the injection and its APIs till the situation improves.(With inputs from PTI.)

  • Print
  • COMMENT
BT-Story-Page-B.gif
A    A   A
close